We have analysed the same IGFI gene polymorphism in UK subjects and we did not observe any of the associations seen in the Dutch study (all trends seen were in the opposite direction). This highlights important methodological issues regarding the design of genetic association studies. We have analysed the IGFI gene polymorphism in 611 subjects from the UK Barry-Caerphilly cohort (BCG), and 348 patients with Type II diabetes [4] and a further 169 subjects from the Exeter Family study of childhood growth (EFS). All subjects gave informed consent with approval from the local research ethics committee in accordance with the declaration of Helsinki. We did not find that the absence of the common allele was associated with Type II diabetes or with any diabetic intermediate traits such as insulin resistance or beta-cell dysfunction. In addition, there was no association with birth weight (Table 1) .
To the Editor:
The fetal insulin hypothesis [1] proposes that genetic factors could explain the association between reduced fetal growth and Type II (non-insulin-dependent) diabetes mellitus. Vaessen et al. have recently tested this hypothesis by first identifying an association between a candidate gene polymorphism, the IGFI promoter microsatellite, and Type II diabetes [2] and then assessing the role of this variant in fetal growth within the same Dutch population [3] . Absence of the common allele was associated with both increased risk of Type II diabetes in 220 patients compared with 596 control subjects and with reduced fetal growth in 463 subjects from the Rotterdam study. Does the IGFI polymorphism or one in linkage disequilibrium with it affect fetal growth? The results from studies so far do not support this. However further studies may be warranted: a recent meta-analysis of 370 genetic association studies has highlighted the need to assess the evidence for or against an association over many studies [5] . In genetic studies of polygenic traits, conflicting results are far more common than concordant results. These problems can be partly overcome by using larger numbers of subjects, requiring smaller p values and by attempting to replicate results in additional cohorts and in family studies. This applies equally to fetal growth as it does to any other polygenic trait. These approaches have been widely advocated [6] but rarely implemented, even in high impact journals.
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